Available in > 45 countries, the MiSeqDx is an in vitro diagnostic (IVD) next-generation sequencing instrument for diagnostics and clinical research.
Regulated platforms with stringent performance characteristics for diagnostic use.
Next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.